Melanotan I

FDA Approved

Melanotan I (Afamelanotide)

Aliases
Afamelanotide, Scenesse
Administration
Subcutaneous implant (FDA-approved route)

Documented benefits

Tier 1 · Peer-reviewed / regulatory

Benefit categories

Aesthetic & Beauty

Melanotan I's defining research application — the only tanning-related peptide in this database with current FDA approval.

Skin pigmentation

Selectively activates the MC1R skin receptor to boost pigment, a more targeted receptor profile than Melanotan II.

Photoprotection

Its FDA-approved effect — providing real sun protection for patients with an inherited light-sensitivity disorder.